Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 6—June 2023
Dispatch

Treatment Failure in Patient with Severe Mpox and Untreated HIV, Maryland, USA

Evgenii Filippov1, Sanchit Duhan1Comments to Author , Laura Lehman, Bijeta Keisham, and Vishal Sethi
Author affiliation: Sinai Hospital of Baltimore, Baltimore, Maryland, USA

Main Article

Figure 1

Changes in skin lesions despite aggressive treatment with antiviral medications in patient with severe mpox and untreated HIV, Baltimore, Maryland, USA: A) left hand, B) face, C) trunk, and D) left arm and elbow. Images at left taken on day 65, after 18 days of tecovirimat and 1 dose of brincidofovir. Images at right taken on day 73, after 26 days of tecovirimat, 2 doses of brincidofovir, and 1 dose of vaccinia immune globulin intravenous.

Figure 1. Changes in skin lesions despite aggressive treatment with antiviral medications in patient with severe mpox and untreated HIV, Baltimore, Maryland, USA: A) left hand, B) face, C) trunk, and D) left arm and elbow. Images at left taken on day 65, after 18 days of tecovirimat and 1 dose of brincidofovir. Images at right taken on day 73, after 26 days of tecovirimat, 2 doses of brincidofovir, and 1 dose of vaccinia immune globulin intravenous.

Main Article

1These first authors contributed equally to this article.

Page created: April 20, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external